- Home
- DDD vs HUMA Comparison
DDD vs HUMA Comparison
Compare DDD & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DDD | HUMA |
|---|---|---|
| Founded | 1986 | 2004 |
| Country | United States | United States |
| Employees | N/A | 184 |
| Industry | Computer peripheral equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 343.2M | 308.6M |
| IPO Year | 2003 | N/A |
Fundamental Metrics
Financial Performance| Metric | DDD | HUMA |
|---|---|---|
| Price | $3.21 | $1.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $4.75 | ★ $6.19 |
| AVG Volume (30 Days) | 5.5M | ★ 7.5M |
| Earning Date | 05-08-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 109.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $386,902,000.00 | N/A |
| Revenue This Year | $2.48 | $444.16 |
| Revenue Next Year | $4.10 | $248.39 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.50 | $0.55 |
| 52 Week High | $4.12 | $2.84 |
Technical Indicators
Market Signals| Indicator | DDD | HUMA |
|---|---|---|
| Relative Strength Index (RSI) | 55.52 | 44.22 |
| Support Level | $2.77 | $0.89 |
| Resistance Level | $3.42 | $1.28 |
| Average True Range (ATR) | 0.27 | 0.12 |
| MACD | -0.06 | -0.05 |
| Stochastic Oscillator | 31.72 | 7.62 |
Price Performance
Historical ComparisonAbout DDD 3D Systems Corporation
3D Systems Corp provide comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, manufacturing and applications engineering. Its solutions support applications in two key industry verticals: Healthcare Solutions provide surgical planning, implants, instrumentation, and medical education solutions to help medical device manufacturers and healthcare providers accelerate, and ultimately, transform healthcare, and Industrial Solutions which includes aerospace, defense, transportation and general manufacturing. The company operates in the Americas, EMEA, and APAC regions.
About HUMA Humacyte Inc.
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.